← Back to patent-cliff list

CAS 253168-94-4

1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine

Codes: APER-002, (XVII)989842-1-b

Application context (from source-drug indications)

Plaque psoriasisApremilastBehçet's syndromeApremilastOral ulcerApremilastPsoriasisApremilastPsoriatic arthritisApremilastPlaque psoriasisMufemilastUlcerative colitisMufemilastBehçet's syndromeMufemilastPsoriasisMufemilastChronic obstructive pulmonary diseaseMufemilastAtopic dermatitisMufemilast

Source drugs (routes using this intermediate)

DrugTierExpiry
ApremilastTier B — Position early2028
MufemilastTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.